KAYNAKLAR
1. McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European journal of heart failure 2012;14:803-69.
2. TKD. Türk Kardiyoloji Derneği (TKD) Ulusal Kalp Sağlığı Politikası. 2007.
3. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction:
prevalence and mortality in a population-based cohort. Journal of the American College of Cardiology 1999;33:1948-55.
4. Degertekin M, Erol C, Ergene O et al. [Heart failure prevalence and predictors in Turkey: HAPPY study]. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 2012;40:298-308.
5. ENAR R. Kanita Dayali Kalp Yetersizliği Kitabi: Nobel Tıp Kitabevleri Ltd. Şti., 2010.
6. Braunwald E. A textbook of Cardiovascular Medicine. 9 ed. Philadelphia:
Saunders/Elsevier, 2012.
7. Braunwald E., Ross J., Sonnenblick E.H.; Medical progress. Mechanisms of contraction of the normal and failing heart. N Engl J Med. 1967;277:794-800
8. Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Journal of the American College of Cardiology 2001;38:2101-13.
9. Feldman AM, Li YY, McTiernan CF. Matrix metalloproteinases in pathophysiology and treatment of heart failure. Lancet 2001;357:654-5.
10. Braunwald E. Clinical aspects of heart failure. In: Braunwald E, ed. High-output failure;
pulmonary edema’ in heart disease. Philadelphia: WB Saunders, 2001.
11. Hurst J. Diagnosis and management of heart failure. In: Hurst JW, ed. The heart. 10th ed. International Edition ed: McGraw Hill, 2001.
12. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. European heart journal 2001;22:1527-60.
13. Cazeau S, Leclercq C, Lavergne T et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. The New England journal of medicine 2001;344:873-80.
14. Shinbane JS, Chu E, DeMarco T et al. Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure.
Journal of the American College of Cardiology 1997;30:1295-300.
15. Shamim W, Francis DP, Yousufuddin M et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. International journal of cardiology 1999;70:171-8.
16. Iuliano S, Fisher SG, Karasik PE, Fletcher RD, Singh SN. QRS duration and mortality in patients with congestive heart failure. American heart journal 2002;143:1085-91.
17. Cazeau S, Ritter P, Bakdach S et al. Four chamber pacing in dilated cardiomyopathy.
Pacing and clinical electrophysiology : PACE 1994;17:1974-9.
18. Daubert JC, Ritter P, Le Breton H et al. Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing and clinical electrophysiology : PACE 1998;21:239-45.
19. Auricchio A, Stellbrink C, Block M et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999;99:2993-3001.
20. Auricchio A, Stellbrink C, Sack S et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. Journal of the American College of Cardiology 2002;39:2026-33.
21. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the National Heart Failure project.
American heart journal 2002;143:412-7.
22. Higgins SL, Hummel JD, Niazi IK et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. Journal of the American College of Cardiology 2003;42:1454-9.
23. Young JB, Abraham WT, Smith AL et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA : the journal of the American Medical Association 2003;289:2685-94.
24. Yu CM, Chau E, Sanderson JE et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002;105:438-45.
25. Linde C, Ellenbogen K, McAlister FA. Cardiac resynchronization therapy (CRT):
clinical trials, guidelines, and target populations. Heart rhythm : the official journal of the Heart Rhythm Society 2012;9:S3-S13.
26. Brecker SJ, Xiao HB, Sparrow J, Gibson DG. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992;340:1308-12.
27. Nishimura RA, Hayes DL, Holmes DR, Jr., Tajik AJ. Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. Journal of the American College of Cardiology 1995;25:281-8.
28. Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation 1989;79:845-53.
29. Ozdemir K, Altunkeser BB, Danis G et al. Effect of the isolated left bundle branch block on systolic and diastolic functions of left ventricle. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2001;14:1075-9.
30. Cleland JG, Daubert JC, Erdmann E et al. The CARE-HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end-points. European journal of heart failure 2001;3:481-9.
31. Penicka M, Bartunek J, De Bruyne B et al. Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography. Circulation 2004;109:978-83.
32. Fung JW, Yu CM, Yip G et al. Variable left ventricular activation pattern in patients with heart failure and left bundle branch block. Heart 2004;90:17-9.
33. Ansalone G, Giannantoni P, Ricci R et al. Doppler myocardial imaging in patients with heart failure receiving biventricular pacing treatment. American heart journal 2001;142:881-96.
34. Pitzalis MV, Iacoviello M, Romito R et al. Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony. Journal of the American College of Cardiology 2002;40:1615-22.
35. Bax JJ, Molhoek SG, van Erven L et al. Usefulness of myocardial tissue Doppler echocardiography to evaluate left ventricular dyssynchrony before and after biventricular pacing in patients with idiopathic dilated cardiomyopathy. The American journal of cardiology 2003;91:94-7.
36. Bader H, Garrigue S, Lafitte S et al. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. Journal of the American College of Cardiology 2004;43:248-56.
37. Breithardt OA, Sinha AM, Schwammenthal E et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. Journal of the American College of Cardiology 2003;41:765-70.
38. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy, The Task Force on cardiac pacing and resynchronization therapy of the European Society
of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J (2013) 34 (29): 2281-2329.
39. Elster SK, Braunwald E, Wood HF. A study of C-reactive protein in the serum of patients with congestive heart failure. American heart journal 1956;51:533-41.
40. Yu CM, Fung JW, Zhang Q et al. Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure. Journal of cardiac failure 2005;11:S42-6.
41. Pavlopoulos H, Nihoyannopoulos P. Recent advances in cardiac resynchronization therapy: echocardiographic modalities, patient selection, optimization, non-responders--all you need to know for more efficient CRT. The international journal of cardiovascular imaging 2010;26:177-91.
42. Bax JJ, Marwick TH, Molhoek SG et al. Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation. The American journal of cardiology 2003;92:1238-40.
43. Vidal B, Delgado V, Mont L et al. Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure. European journal of heart failure 2010;12:283-7.
44. Ypenburg C, Schalij MJ, Bleeker GB et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 2007;28:33-41.
45. Caro CG, Pedley TJ, Schroter RC, Seed WA: The Mechanics of the Circulation.New York, Oxford University Press,1978,pp243-349.
46. Nichols WW, O’Rourke M:Mc Donald’s Blood Flow in Arteries:Theoretical, Experimental and Clinical Principles,ed 4. London, Arnold, 1998,pp54-401.
47. Safar ME,Levy BI, Struijker-Boudier H: Current perspectives on arteriel stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003;107:2864-2869.
48. Chae CU, Pfeffer MA, Glynn RJ, Mitchell GF, Taylor JO, and Hennekens CH.Increased pulse pressure and risk of heart failure in the elderly. JAMA 281:634–
639; 1999.
49. Franklin SS, Larson MG, Khan SA, Wong ND, Kannel WB, and Levy D. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 103:1245–1249; 2001.
50. Mitchell GF, Pfeffer MA, Braunwald E, Rouleau J-L, Bernstein V, Geltman EM,and Flaker GC. Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. Circulation 96: 4254- 4260;1997.
51. Vaccarino V, Berger A, Abramson J, Black H, Setaro J, Davey J, Krumholz H.Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol 88: 980–986; 2001.
52. Kostis J, Lawrence-Nelson J, Ranjan R, Wilson A, Kostis W, Lacy C. Association of increased pulse pressure with the development of heart failure in SHEP. Systolic Hypertension in the Elderly (SHEP) Cooperative Research Group. Am J Hypertens 14:
798–803; 2001.
53. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99: 2434 –2439; 1999.
54. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR,Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J. Prevention of dementia in randomised double-blind placebo- controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352:1347–1351; 1998.
55. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard, J-L., Ducimetie`re P, and Guize L. Pulse pressure: a predictor of long-term cardiovascular mortality in a french male population. Hypertension 30: 1410 –1415; 1997.
56. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: Circ Res 90: 251–262; 2002.47
57. Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries.
Arterioscler Thromb 13: 90 –97; 1993.
58. Darne B, Girerd X, Safar M: Pulsatile versus steady component of bloodpressure:a cross sectional analysis and a prospective analysis on CV mortality:Hypertension 1989;13:392-400.
59. Benetos A, Safar M,et al: Pulse pressure: a predictor of long termcardiovascular mortality in a French male population: Hypertension1997;30:1410-1415.
60. Domanski MJ, Mitchell GF, et al: Independent prognostic informationprovided by sphyigmomanometrically determined pulse pressure and meanarterial pressure in patients with LV dysfunction. J Am Coll Cardio 1999;33:951-958.
61. Boutouyrie P, et al: Aortic stiffness is an independent predictor of primarycoronary events in hypertensive patients. Hypertension 2002;39:10-15.
62. Triposkiadis F, et al: A comparative study of the effect of coronary arterydisease on ascending and abdominal aorta distensibility and PWV. Acta Cardio 1993;48:221-233.
63. Barenbrock M, Spieker C, Kerber S, Vielhauer C, et al: Different effects o hypertension, atherosclerosis and hyperlipidemia on arterial distensibility. Hypertens 1995;13:1712-1717.
64. Cameron JD, Jennings GL, Dart AM: Systemic arterial compliance i decreased in newly-diagnosed patients with coronary heart disease:implicationfor prediction of risk.
J Cardivasc Risk 1996;3:495-500.
65. Waddell TK, Dart AM, Medley TL, Cameron JD Kingwell BA: Caroti pressure is a better predictor of coronary artery disease severity than brachia pressure.
Hypertension 2001;38:927-931.
66. Lim HE, Park CG, Shin SH, Ahn JC, Seo HS, Oh DJ: Aortic pulse wave velocity as an independent marker of coronary artery disease. Blood Pres 2004;13:369-375.
67. Vihert AM: Atherosclerosis of the aorta and coronary arteries in coronar heart disease.
Bull World Health Organ 1976;53:585-596.
68. Mitchell GF, DeStefano AL, Larson MG, et al: Heritability and a genomewid linkage scan for arterial stiffness, wave reflection, and mean arteria pressure: The Framingham Heart Study. Ciculation 2005;112:194-199.
69. Medley TL, Cole TJ, Gatzka CD, et al:Fibrillin-1 genotype is associate with aortic stiffness and disease severity in patients with coronary artery disease Circulation 2002;19:810-815.
70. Medley TL, Kingwell BA, Gatzka CD, et al: Matrix metalloproteinase 3genotype contributes to age-related aortic stiffening through modulation o gene and protein expression. Circ Res 2003;92:1254-1261.
71. Medley TL, Kingwell BA, Gatzka CD: Matrix metalloproteinase-9genotyp influences largeartery stiffness through effects on aortic gene and protei expression. Arterioscler Thromb Vasc Biol 2004;24:1479-1484.
72. Durier S, Fassot C, Laurent S, et al: Physiological genomix of huma arteries:
Quantitative relationship between gene expression and arteriel stiffness. Circulation 2003;108:1845-1851.
73. Benetos A, Gautier S, et al: Influence of angiotensin-converting enzyme an angiotensin II type 1 receptor gene polimorphisms on aortic stiffness i normotensive and hypertensive patients. Circulation 1996;94:698-703.
74. Antikainen R, Jousilahti P, Tuomilehto J: Systolic blood pressure,isolate systolic hypertension and risk of coronary heart disease, strokes, cardiovascula disease and all-cause mortality in the middle-aged population. J Hyperten 1998;16:577-583.
75. Rajkumar C, Cameron JD, Christophidis N, et al: Reduced systemic arteria compliance is associated with left ventricular hypertrophy and diastoli dysfunction in older people. J Am Geriatr Soc 1997;45:803-808.
76. Nitta K, Akiba T, Uchida K, et al: Left ventricular hypertrophy is associate with arterial stiffness and vascular calcification in hemodialysis patients Hypertens Res 2004;27:47-52.
77. Lekakis JP, et al:Arterial Stiffness assessed by pulse wave analysis i essential hypertension:relation to 24-hour blood pressure profile. Int J Cardio 2005;102:391-395.
78. Xu C, Zarins CK, Pannaraj PS, Bassiouny HS, Glagov S Hypercholesterolemia superimposed by experimental hypertension induce differential distribution of collagen and elastin. Arterioscler Thromb Vasc Bio 20: 2566 –2572; 2000.
79. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascula disease enterprises: Part III: cellular and molecular clues to heart and arteria aging. Circulation 2003;107:490–497.
80. Li Z, Froehlich J, and Galis ZS. Increased expression of matri metalloproteinase–2 in the thickened intima of aged rats. Hypertension 33: 116 1999.
81. Avolio A, Jones D, Tafazzoli-Shadpour M. Quantification of alterations i structure and function of elastin in the arterial media.Hypertension 32: 170 175;1998.
82. Verzijl N, DeGroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, Bijlsma JW,Lafeber FP, Baynes JW, TeKoppele JM. Effect of collagen turnover on th accumulation of advanced glycation end products. J Biol Chem 275:39027– 39031; 2000.
83. Rojas A, Romay S, Gonzalez D, Herrera B, Delgado R, Otero K. Regulatio of endothelial nitric oxide synthase expression by albuminderived advance glycosylation end products. Circ Res 86: E50–E54; 20
84. Kuzuya M, Asai T, Kanda S, Maeda K, Cheng XW. Glycation cross- linksinhibit matrix metalloproteinase-2 activation in vascular smooth muscle cellscultured on collagen l attice. Diabetologia 44: 433– 436; 2001.
85. Wendt T, Bucciarelli L, Qu W, Lu Y, Yan SF, Stern DM, Schmidt AM.Receptor for Advanced Glycation Endproducts (RAGE) and VascularInflammation:Insight into the Pathogenesis of Macrovascular Complications inDiabetes. Curr Atheroscler Rep 4:
228 –237; 2002.
86. Schmidt AM, Stern D. Atherosclerosis and diabetes: the RAGE connection. Curr Atheroscler Rep 2: 430–436; 2000.48
87. Giannattasio C, Mangoni AA, Failla M, Carugo S, Stella ML, Stefanoni P,Grassi G, Vergani C, Mancia G. Impaired radial artery compliance innormotensive subjects with familial hypercholesterolemia. Atherosclerosis124:249 –260; 1996.
88. Levy D, DeStefano AL, Larson MG, O’Donnell CJ, Lifton RP, Gavra H, Cupples LA, Myers RH. Evidence for a gene influencing blood pressure on chromosome 17.
Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension 2000;36:477– 483.
89. Lajemi M, Gautier S, Poirier O, Baguet JP, Mimran A, Gosse P, Hanon O, LabatC, Cambien F, Benetos A. Endothelin gene variants and aortic and cardiac structure in never-treated hypertensives. Am J Hypertens 14: 755–760; 2001.
90. Brull DJ, Murray LJ, Boreham CA, Ralston SH, Montgomery HE, Gallagher AM,McGuigan FE, Davey SG, Savage M, Humphries SE, Young IS. Effect of a COL1A1 Sp1 binding site polymorphism on arterial pulse wave velocity: an index of compliance. Hypertension 38: 444–448; 2001.
91. Schut AF, Janssen JA, Deinum J, Vergeer JM, Hofman A, Lamberts SW, Oostra BA, Pols HA, Witteman JC, van Duijn CM. Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension. Stroke 34: 1623–1627; 2003.
92. Najjar SS, Scuteri A, Lakatta EG: Arterial aging: is it an immutable cardiovascular risk factor? Hypertension 2005;46:454-462.
93. Lakatta EG, Levy D: Arterial and cardiac aging:major shareholders in cardiovascular disease enterprises.I. Aging arteries: a set up for vascular disease.
94. Izzo JL Jr.Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol.
2004;19(4):341-52.
95. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness.
Hypertension. 2005;45(6):1050-5.
96. O’Rourke MF, Staessen JA, Vlachopoulos C, Duprez D, Plante GE. Clinical applications of arterial stiffness: definitions and reference values. Am J Hypertens.2002;15:426-444.
97. Latham RD, Westerhof N, Sipkema P, Rubal BJ, Reuderink P, Murgo JP. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures. Circulation 1985;72:1257–1269.
98. Willum-Hansen T, Staessen JA, Torp- Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J.Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population. Circulation 2006;113;664-670.
99. Laurent S, Cockcroft J, Van Bortel L, et all.European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness:
methodological issues and clinical applications. Eur Heart J 2006;27:2588–605.
100. Rajzer MW, Wojciechowska W, Klocek M, Palka I, Brzozowska-Kiszka M, Kawecka-Jaszcz K. Comparison of aortic pulse wave velocity measured by three techniques:
Complior, SphygmoCor and Arteriograph. J Hypertens. 2008;26(10):2001-7.
101. Chirinos JA, Zambrano JP, Chakko S, Veerani A, Schob A, Willens HJ, Perez G, Mendez AJ.Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension. 2005;45(5):980-5 102. Asmar R: Pulse wave velocity, principles and measurement In: Asmar R, editor. Arterial
stiffness and pulse wave velo-city, clinical applications. France: Elsevier, 1999:25-55 103. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F:
Continuous relation between left ventricular masa and cardiovascular risk in essential hypertension. Hypertension 2000;35:580-6
104. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991;114:345-52
105. Jokiniitty JM, Majahalme SK, KWıönen MAP, Tuomisto MT, Turjanmaa VMH: Pulse pressııre is the best predictor of future left ventricular mass and change in left ventricular mass: 10 years of follow up. J Hypertens 2001;19:2047- 54
106. Dame B, Girerd X, Safar M, Cambien F, Guize L: Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardio-vascular mortality. Hypertension 1989;13:392-400
107. Pannier B, Brunel P, El Aroussy W, Lacolley P, Safar ME: Pulse pressure and echocardiographic findings in essential hypertension. J Hypertens 1989;7:127-32 108. Khattar RS, Acharya DU, Kinsey C, Senior R, Lahiri A: Longitudinal association of
ambulatoiy pulse pressure with left ventricular mass and vascular hypertrophy in essential hypertension. J Hypertens 1997;15:737-43
109. Dornanski MJ, Mitchell GF, Norman JE, Exner DV, Pitt B, Pfeffer MA: Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 1999;33:951-8
110. Dart AM, Kingwell BA: Pulse pressure — a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001;37:975-84
111. Safar ME: Pulse pressure in essential hypertension: clinical and therapeutical implications (editorial review). J Hypertens 1989;7:769-76
112. Pepine CJ, Nichols WW, Conti CR: Aortic input impedance in heart failure. Circulation 1978;58:460-465
113. Hirsch AT, Dzau VJ, Creager MA: Baroreceptor function in congestive heart failure.
Circulation 1987;75(suppl IV): IV-36-IV-48
114. Zelis R, Flaim SF: Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982;24:437-459
115. Laurent S, Lacolley P, London G, Safar M: Hemodynamics of the carotid artery after vasodilation in essential hypertension. Hypertension 1988;11:134-140
116. O'Rourke MF: Arterial Function in Health and Disease. New York, Churchill Livingstone, Inc, 1982, pp 153-167
117. Laskey WK, Kussmaul WG: Arterial wave reflection in heart failure. Circulation 1987;75:711-722
118. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ: Left ventricular end-systolic volume is the majör determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51
119. Stefanadis C, Wooley CF, Bush CA, Kolibash AJ, Boudoulas H: Aortic distensibility abnormalities in coronary artery disease. Am J Cardiol 1987;59:1300-1304
120. Zelis R, Delea CS, Coleman HN, Mason DT: Arterial sodium content in experimental congestive heart failure. Circulation 1970;41:213-216
121. Francis GS, Goldsmith SR, Levine TB, Olivari MT, Cohn JN: The neurohormonal axis in congestive heart failure. Ann Intern Med 1984;101:370-377
122. Dzau VJ, Safar ME: Large conduit arteries in hypertension: Role of the vascular renin-angiotensin system. Circulation 1988;77:947-954
123. Kaiser L, Spickard RD, Olivier NB: Heart failure depresses endothelium-dependent responses in canine femoral artery. Am J Physiol 1989;256:H962-H967
124. Simon ACh, Levenson JA, Bouthier JD, Safar ME: Captopril induced changes in large arteries in essential hypertension. Am J Med 1984;76:71-76
125. Safar ME, Laurent S, Bouthier JD, London GM: Comparative effects of captopril and isosorbide dinitrate on the arterial Wall of hypertensive human brachial arteries. J Cardiovasc Pharmnacol 1986;8:1257-1261
126. Sharpe N, Murphy J, Smith H, Hannan S: Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988;1:255-259
127. Pfeffer MA, Lamas GA, Vaughan D, Parisi AF, Braunwald E: Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-86
128. O'Rourke M, Frohlich ED.Pulse pressure: Is this a clinically useful risk factor?
Hypertension. 1999;34:372-4
129. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 55(13):1318-27
130. Anderson SG, Sanders TA, Cruickshank JK.Plasma fatty acid composition as a predictor of arterial stiffness and mortality. Hypertension 2009;53:839–45.
131. Choi CU, Park EB, Suh SY, et all.Impact of aortic stiffness on cardiovascular disease in patients with chest pain. Assessment with direct intra-arterial measurement. Am J Hypertens 2007;20:1163–9.
132. Orlova IA, Nuraliev EY, Yarovaya EB, Ageev FT. Prognostic value of changes in arterial stiffness in men with coronary artery disease. Vasc Health Risk Manag.
2010;6:1015-21.
133. Gaszner B, Lenkey Z, Illyés M, Sárszegi Z, Horváth IG, Magyari B, Molnár F, Kónyi A, Cziráki A.Comparison of aortic and carotid arterial stiffness parameters in patients with verified coronary artery disease. Clin Cardiol. 2012; 35(1):26-31
134. Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients.
Hypertension. 2005;45(4):592-6